Citius Pharmaceuticals's market cap is currently $15.90M. The company's EPS TTM is $-5.802; its P/E ratio is ―; Citius Pharmaceuticals is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -194.32K	$ -179.68K	$ -164.87K	$ -152.36K
Operating Income	$ 0.00	$ -36.73M	$ -33.32M	$ -23.53M	$ -17.71M
EBITDA	$ 0.00	$ -36.73M	$ -32.88M	$ -22.88M	$ -17.38M
Net Income	$ -39.43M	$ -32.54M	$ -33.64M	$ -23.13M	$ -17.67M
Balance Sheet
Cash & Short-Term Investments	$ 3.25M	$ 26.48M	$ 41.71M	$ 70.07M	$ 13.86M
Total Assets	$ 116.65M	$ 103.61M	$ 114.00M	$ 142.43M	$ 43.77M
Total Debt	$ 262.87K	$ 481.25K	$ 678.23K	$ 855.47K	$ 1.35M
Net Debt	$ -2.99M	$ -26.00M	$ -41.03M	$ -69.22M	$ -12.51M
Total Liabilities	$ 42.55M	$ 12.18M	$ 10.57M	$ 9.65M	$ 10.10M
Stockholders' Equity	$ 70.08M	$ 90.83M	$ 102.83M	$ 132.18M	$ 33.67M
Cash Flow
Free Cash Flow	$ -28.20M	$ -29.06M	$ -28.36M	$ -64.26M	$ -16.93M
Operating Cash Flow	$ -28.20M	$ -29.06M	$ -28.36M	$ -24.25M	$ -16.93M
Investing Cash Flow	$ -5.00M	$ 0.00	$ 0.00	$ -40.01M	$ -1.83K
Financing Cash Flow	$ 9.97M	$ 13.83M	$ 0.00	$ 120.47M	$ 22.90M

Currency in USD

Citius Pharmaceuticals Earnings and Revenue History

Income Statement >

Citius Pharmaceuticals Debt to Assets

Balance Sheet >

Citius Pharmaceuticals Cash Flow

Cash Flow >

Citius Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing